Atea Pharmaceuticals, Inc.
USD4.62
+0.01 (+0.22%)
CEO
Jean-Pierre Sommadossi
IPO Date
2020-10-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.61
Prev. Close
$4.61
Day Low
$4.49
Day High
$4.68
52W Low
$2.78
52W High
$6.45
Market Cap
$0.37B
Volume
0.13M
| -1.7 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -24.5% | -22.9% | 0.00 | 18.24 | -1.9 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -18.1% | -17.4% | 0.00 | 35.77 | -3.5 |
| 31 Dec 2021 | FY | 52.4% | 34.5% | 17.1% | 15.7% | 0.00 | 13.58 | 6.1 |
| 31 Dec 2020 | FY | 21.8% | -22.5% | -2.0% | -1.3% | 0.00 | 2.73 | -314.6 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -68.9% | -61.0% | 0.00 | 9.00 | -186.2 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 25.1% | -26.0% | 0.00 | 19.71 | -33.8 |
| -1.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -13.3% | -12.3% | 0.00 | 16.66 | -1.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -10.2% | -9.5% | 0.00 | 19.17 | -2.0 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -8.3% | -7.8% | 0.00 | 19.94 | -1.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -7.6% | -7.2% | 0.00 | 24.85 | -2.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -6.8% | -6.3% | 0.00 | 19.33 | -2.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -8.5% | -7.9% | 0.00 | 19.02 | -1.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -12.5% | -11.4% | 0.00 | 13.28 | -1.3 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -7.1% | -6.6% | 0.00 | 18.24 | -1.6 |